Login / Signup

Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study.

Ying FengJianying HuangJianyuan WuYan XuBo ChenLijun JiangHui XiangZhiyong PengXing-Huan Wang
Published in: Cell proliferation (2020)
Intravenous transplantation of UC-MSCs was safe and feasible for treatment of patients with severe and critically severe COVID-19 pneumonia.
Keyphrases
  • umbilical cord
  • mesenchymal stem cells
  • cell therapy
  • coronavirus disease
  • early onset
  • sars cov
  • bone marrow
  • high dose
  • respiratory failure
  • community acquired pneumonia
  • intensive care unit
  • low dose